Home » Stocks » GTHP

Guided Therapeutics, Inc. (GTHP)

Stock Price: $0.780 USD -0.010 (-1.27%)
Updated May 4, 2021 4:00 PM EDT - Market closed
Market Cap 10.21M
Revenue (ttm) 102,000
Net Income (ttm) n/a
Shares Out 13.30M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 4
Last Price $0.780
Previous Close $0.790
Change ($) -0.010
Change (%) -1.27%
Day's Open 0.695
Day's Range 0.690 - 0.780
Day's Volume 4,203
52-Week Range -

News

There are no news available yet.

About GTHP

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 199... [Read more...]

Industry
Medical Devices
IPO Date
Jul 1, 1997
CEO
Gene Cartwright
Employees
6
Stock Exchange
OTCMKTS
Ticker Symbol
GTHP
Full Company Profile